Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
fda
new york top stories
san diego blog main
san francisco top stories
aligos therapeutics
antibiotics
arvinas
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
avidity biosciences
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
bluebird bio
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
cavion
celgene
cephalgia
chronic hepatitis b virus
david goldstein
demodex blepharitis
depression
detroit
What
biotechs
3
×
ipos
3
×
ipo
medicines
way
ago
central
chose
close
cns
company
considering
data
device
diseases
disorder
drug
drugs
dyne
early
emerged
expected
experimental
eyes
firms
genetic
having
humans
kept
leads
life
long
make
medical
muscle
nervous
open
praxis
precision
prep
Language
unset
Current search:
ipos
×
biotechs
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
